Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Retrievable IVC square stent filter: Experimental study

    Purpose: In vitro and in vivo evaluation of a new retrievable, home-made, inferior vena cava (IVC) Square stent filter (SSF) with two trap** levels.

    Dusan Pavcnik, Barry T. Uchida in CardioVascular and Interventional Radiology (1999)

  2. No Access

    Article

    Endoluminal Treatment of Ruptured Abdominal Aortic Aneurysm with Small Intestinal Submucosa Sandwich Endografts: A Pilot Study in Sheep

    To evaluate efficacy of small intestinal submucosa (SIS) Sandwich endografts for the treatment of acute rupture of abdominal aortic aneurysms (AAA) and to explore the short-term reaction of the aorta to this m...

    Katsuyuki Yamada, Dusan Pavcnik M.D., Ph.D. in CardioVascular and Interventional Radiology (2001)

  3. No Access

    Article

    Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT

    More than 90% of gastrointestinal stromal tumors (GISTs) express the receptor tyrosine kinase KIT, and activating mutations of the KIT gene are detectable in the vast majority of these tumors. Imatinib mesylat...

    Sebastian Bauer, Christopher L. Corless in Cancer Chemotherapy and Pharmacology (2003)

  4. No Access

    Article

    c-CBL is not required for leukemia induction by Bcr-Abl in mice

    Bcr-Abl tyrosine kinase activity is essential for the pathogenesis of chronic myeloid leukemia (CML). A number of Bcr-Abl substrates have been identified, but it is not clear which of these substrates are require...

    Daniela M Dinulescu, Lisa J Wood, Lei Shen, Marc Loriaux, Christopher L Corless in Oncogene (2003)

  5. No Access

    Chapter

    Targeting mutant kinases in Gastrointestinal Stromal Tumors: A paradigm for molecular therapy of other sarcomas

    Michael C. Heinrich MD in Targeting Treatment of Soft Tissue Sarcomas (2004)

  6. No Access

    Article

    Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

    Most GISTs require oncogenic activation of the KIT or PDGFRA receptor tyrosine kinase proteins, and the genomic mechanisms of oncogene activation are heterogeneous. Notably, the kinase mutation type correlates wi...

    Subbaya Subramanian, Robert B West, Christopher L Corless, Wenbin Ou in Oncogene (2004)

  7. No Access

    Article

    Experimental Percutaneous Extrahepatic Portacaval Shunt Creation by Transjugular Approach in Swine

    The purpose of the study was to evaluate the feasibility of the creation of a percutaneous extrahepatic portacaval shunt (PEPS) in swine by a transjugular approach and to find a suitable stent-graft to use in ...

    Chang Kyu Seong, Dusan Pavcnik in CardioVascular and Interventional Radiology (2005)

  8. No Access

    Article

    Effects of Blood Flow and/or Ventilation Restriction on Radiofrequency Coagulation Size in the Lung: An Experimental Study in Swine

    The purpose of this study was to investigate how the restriction of blood flow and/or ventilation affects the radiofrequency (RF) ablation coagulation size in lung parenchyma. Thirty-one RF ablations were done...

    Hiroshi Anai, Barry T. Uchida, Dusan Pavcnik in CardioVascular and Interventional Radiology (2006)

  9. No Access

    Article

    Does tumor mutational status correlate with clinical response to imatinib?

    Michael C Heinrich, Christopher L Corless in Nature Clinical Practice Oncology (2006)

  10. No Access

    Article

    Percutaneous Vein Occlusion with Small Intestinal Submucosa: An Experimental Pilot Study in Swine and Sheep

    The objective of this study was to investigate the feasibility, outcomes, and amount of small intestinal submucosa (SIS) material needed for embolization of jugular vein (JV) in a swine and sheep model. Our hy...

    Man Deuk Kim, Hanno Hoppe, Dusan Pavcnik in CardioVascular and Interventional Radiology (2007)

  11. No Access

    Article

    Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma

    Mutationally activated protein kinases are appealing therapeutic targets in breast carcinoma. Mutations in phosphatidylinositol-3-kinase (PI3KCA) have been described in 8–40% of invasive breast carcinomas, and AK...

    Jennifer Dunlap, Claudia Le, Arielle Shukla in Breast Cancer Research and Treatment (2010)

  12. No Access

    Article

    Absence of BRAF, NRAS, KRAS, HRAS Mutations, and RET/PTC Gene Rearrangements Distinguishes Dominant Nodules in Hashimoto Thyroiditis from Papillary Thyroid Carcinomas

    Dominant nodules within Hashimoto thyroiditis (HT) may present with unique morphological features that overlap with but are not diagnostic of papillary thyroid carcinoma (PTC). Activating BRAF point mutations, RA...

    Peter M. Sadow, Michael C. Heinrich, Christopher L. Corless in Endocrine Pathology (2010)

  13. No Access

    Article

    Oncogenes in context

    In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second prot...

    Michael C. Heinrich, Christopher L . Corless in Nature (2010)

  14. No Access

    Chapter

    Practical Gastrointestinal Oncology Correlative Science

    Gastrointestinal (GI) cancers, like other human malignancies, are characterized by the accumulation of a variety of genetic alterations, including mutations that lead to inactivation of tumor suppressor genes ...

    Kay Washington, Christopher L. Corless in Gastrointestinal Oncology (2011)

  15. No Access

    Article

    Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics

    Liver biopsy remains the gold standard to assess hepatic fibrosis. It is desirable to predict hepatic fibrosis without the need for invasive liver biopsy. Proteomic techniques allow unbiased assessment of prot...

    Libang Yang, Kyle D. Rudser, LeeAnn Higgins in Digestive Diseases and Sciences (2011)

  16. No Access

    Article

    Gastrointestinal stromal tumours: origin and molecular oncology

  17. Gastrointestinal stromal tumours (GISTs) are a family of tumours thought to arise from the interstitial cells of Cajal in the gastrointestinal tract. Recently,...

  18. Christopher L. Corless, Christine M. Barnett, Michael C. Heinrich in Nature Reviews Cancer (2011)

  19. Article

    Open Access

    Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)

    About 10-15% of adult gastrointestinal stromal tumors (GIST) and the vast majority of pediatric GIST do not harbour KIT or platelet-derived growth factor receptor alpha (PDGFRA) mutations (J Clin Oncol 22:3813–38...

    Margherita Nannini, Annalisa Astolfi, Milena Urbini, Valentina Indio in BMC Cancer (2014)

  20. Article

    Open Access

    SDHC methylation in gastrointestinal stromal tumors (GIST): a case report

    Gastrointestinal stromal tumors (GIST) recently have been recognized as a genetically and biologically heterogeneous disease. In addition to KIT or PDGFRA mutated GIST, mutational inactivation of succinate dehydr...

    Milena Urbini, Annalisa Astolfi, Valentina Indio in BMC Medical Genetics (2015)

  21. Article

    Open Access

    IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma

    Risk or presence of metastasis in medulloblastoma causes substantial treatment-related morbidity and overall mortality. Through the comparison of cytokines and growth factors in the cerebrospinal fluid (CSF) o...

    Matthew N. Svalina, Ken Kikuchi, **u Abraham, Sangeet Lal in Scientific Reports (2016)

  22. Article

    Open Access

    FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

    About 10–15% of adult, and most pediatric, gastrointestinal stromal tumors (GIST) lack mutations in KIT, PDGFRA, SDHx, or RAS pathway components (KRAS, BRAF, NF1). The identification of additional mutated gene...

    Eileen Shi, Juliann Chmielecki, Chih-Min Tang in Journal of Translational Medicine (2016)

previous disabled Page of 2